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Abstract
Parasitic hookworms and the free-living model nematode Caenorhabtidis elegans share a developmental arrested stage,
called the dauer stage in C. elegans and the infective third-stage larva (L3) in hookworms. One of the key transcription
factors that regulate entrance to and exit from developmental arrest is the forkhead transcription factor DAF-16/FoxO.
During the dauer stage, DAF-16 is activated and localized in the nucleus. DAF-16 is negatively regulated by phosphorylation
by the upstream kinase AKT, which causes DAF-16 to localize out of the nucleus and the worm to exit from dauer. DAF-16 is
conserved in hookworms, and hypothesized to control recovery from L3 arrest during infection. Lacking reverse genetic
techniques for use in hookworms, we used C. elegans complementation assays to investigate the function of Ancylostoma
caninum DAF-16 during entrance and exit from L3 developmental arrest. We performed dauer switching assays and
observed the restoration of the dauer phenotype when Ac-DAF-16 was expressed in temperature-sensitive dauer defective
C. elegans daf-2(e1370);daf-16(mu86) mutants. AKT phosphorylation site mutants of Ac-DAF-16 were also able to restore the
dauer phenotype, but surprisingly allowed dauer exit when temperatures were lowered. We used fluorescence microscopy
to localize DAF-16 during dauer and exit from dauer in C. elegans DAF-16 mutant worms expressing Ac-DAF-16, and found
that Ac-DAF-16 exited the nucleus during dauer exit. Surprisingly, Ac-DAF-16 with mutated AKT phosphorylation sites also
exited the nucleus during dauer exit. Our results suggest that another mechanism may be involved in the regulation DAF-16
nuclear localization during recovery from developmental arrest.
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Introduction
The insulin/insulin growth factor (IIS) pathway is involved in
embryogenesis [1], cell differentiation [2], development, and aging
[3,4] in diverse species. In the free-living nematode Caenorhabditis
elegans, this pathway mediates entry into and exit from the
developmentally arrested dauer stage by negatively regulating the
activity of a FoxO-family forkhead transcription factor DAF-16
[5–10]. The developmentally arrested, resistant dauer stage allows
C. elegans to survive in unfavorable environments for several
months after its second molt [11]. In C. elegans, DAF-16 localizes to
the nucleus under dauer-inducing conditions, where it binds to
promoter regions of target genes that induce and maintain dauer
[8,12]. In responses to IIS, DAF-16 is phosphorylated by the
activated serine-threonine protein kinase AKT/protein kinase B
(AKT/PKB), therefore creating binding sites for 14-3-3 proteins
(FTT). Interaction between FTT and phosphorylated DAF-16
results in its nuclear exclusion and cytoplasmic retention leading to
reproductive growth [13,14].
The free-living infective third stage larvae (L3) of parasitic
nematodes, such as hookworm, are biologically and functionally
analogous to the C. elegans dauer stage [15–17]. During infection,
hookworm L3 encounter a signal in the host that activates
suspended developmental pathways that lead to resumption of
development and progression to the L4 and adult stages. This
is exactly analogous to recovery from dauer in response to
environmental cues in C. elegans. Therefore, the ‘‘dauer parasitism
hypothesis’’ proposes that common molecular mechanisms mediate
both the resumption of development by hookworms during
infection of the host, and recovery from the dauer stage in response
to improved environmental conditions in C. elegans [17–19].
The inability to resume development in vitro necessitates main-
taining hookworms in an animal host, which precludes the
development of genetic systems. Consequently, little is known
about the molecular events of early infection. What is known is
centered on the larval activation process, in which L3 can be
induced to resume feeding and secrete infection-associated
molecules in vitro [20–25]. Evidence indicates that activation is
regulated by IIS and DAF-16 in hookworms. Orthologs of C.
elegans DAF-16 and 14-3-3, Ac-DAF-16 and Ac-FTT-2, have been
identified recently from the hookworm Ancylostoma caninum [26,27].
Ac-DAF-16 contains a highly conserved forkhead DNA-binding
domain and three potential AKT phosphorylation sites (S107,
T312, and S381). Recombinant Ac-DAF-16 bound to and drove
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transcription from a consensus binding element found in the
promoters of FoxO/DAF-16 target genes from C. elegans and
mammals [26]. Ac-DAF-16 also bound recombinant Ac-FTT-2, an
interaction that required intact AKT phosphorylation sites [27].
These experiments indicated that Ac-DAF-16 is a functioning
transcription factor and further support that IIS pathway plays a
critical role for hookworm L3 re-activation during infection.
In the present study, we used in vitro and heterologous systems to
investigate the mechanism of DAF-16 action. We demonstrate that
the predicted sites on Ac-DAF-16 are phosphorylated by AKT in
vitro. Using cell culture, we show that Ac-DAF-16 is negatively
regulated by IIS, and that Ac-DAF-16 is exported from the nucleus
in response to IIS. Finally, using transgenic C. elegans, we
demonstrate that Ac-DAF-16 partially complements daf-16 loss of
function mutations to restore dauer formation. Our studies lend
support for the dauer parasitism hypothesis, and indicate that the
IIS pathway is important, but not exclusively responsible for the
regulation of recovery from the arrested L3 via Ac-DAF-16.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the George Washington University
Medical Center Institutional Animal Care and Use Committee
(protocol number: A147).
In vitro phosphorylation assay
Ac-DAF-16 has three potential AKT phosphorylation sites base
on primary amino acid sequence analysis. To determine if AKT
phosphorylated Ac-DAF-16 on the predicted sites, 2 mg of
recombinant human AKT (Upstate) were incubated with
1.25 mM rATP (Sigma-Aldrich), 2 mg Ac-DAF-16-peptide and
30 ml kinase buffer from ADP Quest System (Discoverx) for 1 h at
30uC. Three DAF-16 peptides of 15 amino acids length containing
the putative AKT phosphorylation sites were used as substrates.
Crosstide was used as substrate in the positive control, and
reactions with phosphorylated peptides and without AKT and
rATP served as negative controls. The kinase reactions were
stopped by adding ADP detection reagents A and B, and the
fluorescent light emission was determined after 30 minutes at RT
in a 96-well plate reader (DTX Multimode detector Biomek FX/
NX, Beckman Coulter, CA, USA) according the manufacturer’s
instructions. ADP concentrations proportional to the light
emission were calculated from an ADP standard curve. The
kinase reactions were also analysed by Western blotting using
phospho-specific rabbit Ac-DAF-16-peptide antibodies following
SDS-PAGE as described below.
Luciferase assay
In response to IIS, C. elegans DAF-16/FoxO is phosphorylated
by AKT. To determine if Ac-DAF-16 was phosphorylated in
response to IIS, HepG2 cells were co-transfected with pCMV4-Ac-
DAF-16 wildtype or phosphorylation site mutant constructs (single
mutants, S107A, T312A, S381A; double mutants, S107A/T312A;
S107A/S381A, T312A/S381A; and triple mutant, S107A/
T312A/S381A) [27], the luciferase reporter vector p6xDBE-luc
containing 6 copies of the canonical DBE upstream of firefly
luciferase [26] and a Renilla luciferase reporter plasmid as an
internal control. Cells co-transfected with pGL3 vector (Promega)
with intrinsic promoter activity and Renilla reporter plasmid served
as positive control. Transfections were performed in 24 well plates
according to the Genporter3000 protocol (Genlantis). The cells
were grown in Dulbecco’s Modification of Eagle’s medium
(DMEM; Cellgro) supplemented with 10% FBS, 100 U/ml
Penicillin and 0.1 mg/ml Streptomycin (Cellgro) for 24 h. After
incubation, the cells were starved in DMEM without FBS for 16 h
and treated with insulin at a final concentration of 10 ng/ml for
1 h. Finally, the cells were treated with 100 mMAKT inhibitor IV,
AKT inhibitor IX and LY294002 (Calbiochem) for another hour.
Control cells were treated with solvent alone (0.1% DMSO). The
cells were washed and the luciferase activities measured with a
Sirius luminometer using the Dual-Glo Luciferase Assay system
(Promega). Treatments were performed in triplicates. The ratio of
firefly to Renilla luciferase were calculated and the mean and SD
determined. The experiment was repeated three times.
Cell fractionation and Western blot
The mammalian cell line HEK293 was transfected with a
construct encoding full-length wildtype Ac-DAF-16 (clone
Daf16.4Ba.pCMV.2J, [26]) using the lipotransfection reagent
Genporter3000 (Genlantis) in 6 well plates according to the
manufacturer’s instructions. After 48 h in DMEM with 10% FBS
(Gibco), the cells were starved for 24 h in 2 ml medium without
FBS. A mock transfection of HEK293 with the empty pCMV-
Tag4 vector served as a control. After treatment, the cells were
washed three times with 1x PBS-Tween 0.05% (PBS-T) and
fractionated using the Qproteome cell compartment kit (Qiagen).
Following acetone precipitation, the protein fractions were
separated by SDS-PAGE and transferred to nitrocellulose
membranes. The membranes were incubated in 5% skim milk
in 1x PBS-T and subsequently probed with mouse anti-GAPDH
(1:2,000 Abcam), mouse anti-histone (1:500) (Chemicon Interna-
tional) or the rabbit DAF-16 anti-serum (1:20,000) for 16 h at 4uC
with shaking. After three washes in 1x PBS-T, the membranes
were incubated with the HRP-conjugated anti-mouse (1:10,000) or
anti-rabbit (1:5,000) secondary antibody for 1 h at RT. The
washing steps were repeated and the membranes exposed to X-ray
film following incubation with ECL chemiluminescence reagent
(Pierce) for visualization.
Genetic stocks of C. elegans and transformation
constructs
The C. elegans double mutant strain daf-2(e1370);daf-16(mu86)
was used as the parent strain for microinjection and as control in
dauer assays. The control strain daf-2(e1370) was obtained from
the Caenorhabditis Genetics Center (University of Minnesota). The
third control strain, CF1449, was a daf-2(e1370);daf-16(mu86)
double mutant carrying the transgene construct encoding an
N-terminal fusion of GFP and wildtype C. elegans DAF-16
downstream of the daf-16a promoter was kindly provided by
Cynthia Kenyon [28]. All strains were maintained on E. coli OP50
growing on NGM plates at 16uC according to standard methods.
For the complementation experiments, the coding region of wildtype
Ac-daf-16 (GenBank accession number ACD85816) [29] was initially
cloned into pWZ128 with pdpy-30 as the promoter. However, several
of the transgenic lines were unstable. Therefore, the coding region of
Ac-daf-16 was switched into pPV207 to create pWZ401 containing
the C. elegans daf-16a promoter upstream of Ac-daf-16. In a further
step the coding region for GFP was added at the end of the Ac-daf-16
ORF leading to C-terminal GFP fusion protein. Mutant plasmids of
Ac-daf-16 (single mutants, S107A, T312A, S381A; double mutants,
S107A/T312A; S107A/S381A, T312A/S381A; and triple mutant,
S107A/T312A/S381A) were described previously [27]. All con-
structs were confirmed by DNA sequencing.
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Establishment of C. elegans transgenic lines and
complementation assays
Constructs of the transgenes to be tested for rescue were mixed
with marker plasmid (encoding rol-6) at equal volume, both at
100 ng/ml, and injected into gonads of young hermaphrodites
of double mutant strain daf-2(e1370);daf-16(mu86). Microinjected
animals were reared and screened for transformed F1 progeny
based on the roller phenotype. Positive F1 progeny were re-plated
and roller F2 progeny selected again. Positive F2 generation and
beyond were propagated as transgenic lines. Two to six lines per
transgene were obtained.
For dauer switching assays in C. elegans, egg-laying hermaphro-
dites from each transgenic line and control strains were placed on
NGM plates seeded with E. coli OP50 lawns for 3-4 h at RT and
subsequently removed. The plates were incubated at 25uC and
after 96 h animals were scored. For the dauer rescue assay, the
hermaphrodites were sustained on plates. After 96 h, dauer larvae
were isolated by incubation in 1% SDS [11] and transferred to
NGM OP50 plates. The plates were incubated at 16uC and
observed daily for 7 days. The number of worms that developed
were enumerated daily, and subsequently removed from the plate
before they reproduced. Worms that failed to develop or died were
also noted. Dauers isolated from the daf-2(e1370) strain and from
daf-2;daf-16 expressing Ce-DAF-16 were used as controls. All assays
were conducted 3-4 times for each transgenic line, the scores
combined, and the means in percentage displayed. Chi square-
tests (with Yates correction, degrees of freedom =1) were
conducted to determine significant differences between the lines.
Confocal microscopy of transgenic C. elegans strains and
localization of Ac-DAF-16::GFP
Dauer larvae were prepared for confocal microscopy on a Zeiss
LSM 710 with a 20x/1.0 water immersion objective immediately
before image acquisition by transfer into M9 buffer containing
10 mM levamizole. Photographs were taken within 15 min of
removal from incubators and exposure to levamizole. Photomi-
crographs represent?multichannel?l-stacks recorded between 500-
550 nm by a 32-channel spectral detector and reveal both GFP
and autofluorescence as different spectra.
Results
Ac-DAF-16 as substrate of AKT
In C. elegans, AKT modifies DAF-16 at the four phosphorylation
sites (Ser54, Ser240/242, Ser314), thereby creating the binding
site for the FTT-2 interaction [14,30]. We recently showed that
Ac-DAF-16 was immunoprecipated with Ac-FTT-2 from serum-
activated L3 lysates, and that the interaction required intact AKT
phosphorylation sites at Ser107 and Thr312 [27]. To determine if
AKT similarly modified Ac-DAF-16, we incubated 3 peptides
containing the predicted phosphorylation sites (Fig. 1A) with
recombinant AKT in vitro, using ADP formation as an indicator
of kinase activity. As shown in Fig. 1B, the ADP concentration in
all three reactions was significantly increased in the presence of
AKT and the single peptide compared to the negative controls,
indicating that the hydrolysis of ATP by AKT kinase occurred.
The conserved motif for AKT phosphorylation is RxRXXS/
THyd, where x represents any amino acid residue [31], and is
present in all three peptides. In addition to these sites, motif
recognition software [32] predicted a possible AKT phosphory-
lation site adjacent to Thr312 at Ser311. However, there was no
increase in ADP concentration in kinase reactions using a peptide
phosphorylated at Thr312, indicating that Thr312 was the only
reactive site on the peptide, and that Ser311 was not phosphor-
ylated by AKT.
The phosphorylation of the peptides by AKT was verified by
Western blot analysis using phospho-specific anti-DAF-16 anti-
bodies (Fig. 1C). Phosphorylated peptides were detected in the
AKT + ATP + peptide reactions, but not in reactions without the
enzyme. Together, these data indicate that Ac-DAF-16 is
phosphorylated on the conserved residues Ser107, Thr312 and
Ser381 by AKT.
Figure 1. AKT phosphorylates Ac-DAF-16 on conserved phos-
phorylation sites. A) Graphical scheme of Ac-DAF-16 indicating the
localization of the predicted AKT phosphorylation sites at position S107,
T312 and T381 and the peptides (P1, P2, P3) of 15 amino acids lengths
used in the in vitro phosphorylation assay. B) In vitro phosphorylation
assay of Ac-DAF-16 peptides by AKT. The means 6 SD of the ADP
concentration after incubation of rAKT with the Ac-DAF-16 peptides in
the presence of ATP is shown. Crosstide was used as a control substrate.
Negative controls were reactions without AKT as well as phospho-
peptides (PP1, PP2, PP3) containing the phosphorylated residue of
interest. The experiments were repeated three times. Asterisks
represent p- values ,0.05 in T-tests between the sample versus
controls. C) Reactions from the in vitro phosphorylation assay were
separated by PAGE and blotted on nitrocellulose membrane. Proteins
were detected by phospho-specific peptide antibodies as described.
doi:10.1371/journal.pone.0025996.g001
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Sub-cellular localization of Ac-DAF-16
Phosphorylation by AKT, together with our previous studies
[27] suggested that Ac-DAF-16 is regulated by the 14-3-3
dependent shuttling mechanism seen in C. elegans [14]. We used
a cell culture system to determine if Ac-DAF-16 changes sub-
cellular compartments in response to IIS stimulation. HEK293
cells expressing full length wildtype Ac-DAF-16 were incubated
with or without serum, followed by sub-cellular fractionation and
Western blotting to determine the location of DAF-16 (Fig. 2).
Antibody against GAPDH was used as a marker for the
cytoplasmic compartment, and histone H1 for the nuclear
compartment. Both marker proteins were detected at similar
levels in the appropriate fraction. Ac-DAF-16 was detected in both
compartments in serum-starved cells, but only in the cytoplasm in
fed cells, suggesting that Ac-DAF-16 localization is controlled by
IIS, similar to C. elegans DAF-16.
Negative regulation of Ac-DAF-16 transcriptional activity
To analyze the function and regulation of Ac-DAF-16, we
assessed its transcriptional activity from a DAF-16 derived
promoter element under the influence of serum and IIS. Insulin
sensitive HepG2 cells were co-transfected with a construct
encoding full-length Ac-DAF-16, and a reporter construct
containing 6 copies of the DAF-16 binding element (DBE)
upstream of the firefly luciferase gene. A construct encoding
Renilla luciferase under the CMV promoter was also included as an
internal control, and a plasmid encoding constitutively expressed
luciferase served as positive control. The ratios of the luciferase
activity of cells incubated in medium with serum, serum-starved
cells, and cells stimulated with insulin following starvation are
depicted in Figure 3A. Luciferase expression was five-fold higher
in starved cells than serum-fed cells, whereas addition of insulin to
starved cells depressed luciferase expression to the level of serum-
fed cells. Next, inhibitors of IIS were tested for their effects on
insulin stimulated cells. As shown in Figure 3B, AKT inhibitors IV
and IX (Calbiochem) increased normalized luciferase expression
48% and 47%, respectively, and the PI3K inhibitor LY294002
increased expression by 24%. These data confirm that Ac-DAF-16
Figure 2. Ac-DAF-16 is localized in cytoplasm and, in the
absence of IIS, also in the nucleus. Western blot analyses of the
cytosolic (C) and the nuclear (N) fractions of HEK293 cells expressing
Daf16.4Ba.pCMV.2J are shown. After incubation for 2 days in the
presence of 10% FBS, the cells were further cultivated in the medium
containing 10% FBS (lane w/FBS) or medium without FBS (lane w/o FBS)
for 24 h. MOCK cells were transfected with the empty pCMVtag4 vector
and treated as the cells w/o FBS. As controls antibodies against the
cytoplasmic enzyme GAPDH and the nuclear histone were used to
determine the purity of the fractionation.
doi:10.1371/journal.pone.0025996.g002
Figure 3. Gene transcription from DAF-16 binding elements
driven by Ac-DAF-16 is negative regulated by IIS. A) Luciferase
activity of insulin sensitive HepG2 expressing full-length Ac-DAF-16
treated with serum (+ FBS), without serum (2FBS) and insulin (+Ins). B)
Hookworm DAF-16/FoxO Mutant Dauers Exit Dauer
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drives transcription from the DBE in the absence of IIS, and that
IIS negatively regulates DAF-16 mediated reporter transcription.
In C. elegans, AKT phosphorylates DAF-16 on conserved sites in
response to IIS, creating a binding site for the shuttle protein 14-3-3.
The bound DAF-16 is translocated from the nucleus to the
cytoplasm, resulting in negative regulation of DAF-16 transcription.
To determine the mechanism by which insulin negatively regulates
Ac-DAF-16 in cells, the effect of phosphorylation site null mutants
on DAF-16 driven transcription was tested. Ac-DAF-16 constructs
containing single, double and triple mutants of the three AKT
phosphorylation sites were co-transfected with the reporter and
Renilla control plasmids in HepG2 cells. As shown in Figure 3C,
wildtype Ac-DAF-16 drove transcription in the absence of serum,
whereas insulin inhibited transcription. As expected, all of the AKT
site mutants were able to drive transcription from the DBE in the
absence of serum. However, mutation of any of the phosphorylation
sites to Ala prevented inhibition of transcription by insulin. The
higher read-out for mutated Ac-DAF-16 when insulin was added
could be due to longer lasting mutated Ac-DAF-16 which are not
degraded as fast as wildtype Ac-DAF-16 [33]. This indicates that
insulin-induced inhibition of transcription is mediated by phos-
phorylation of the consensus AKT sites, and that mutation of any of
the sites prevents inhibition of transcription by insulin.
Rescue of the dauer phenotype in C. elegans daf-2; daf-16
strain expressing Ac-DAF-16
As genetic manipulation of hookworms is currently not possible,
we used C. elegans as a surrogate to study the function of Ac-DAF-
16 in vivo during dauer entry and exit. Whereas daf-2(e1370)
mutants reared at the restrictive temperature form 100% dauers,
the dauer phenotype is completely suppressed in daf-2(e1370); daf-
16(mu86) double mutants. Thus, rescue of the dauer phenotype in
daf-2(e1370);daf-16(mu86) double mutants provides a convenient
assay for Ac-DAF-16 function in C. elegans. The C. elegans dauer
defective double mutant strain daf-2(e1370);daf-16(mu86) was
complemented with constructs expressing either Ac-DAF-16
wildtype or AKT site phospho-mutants by microinjection and
incubated at the daf-2 restrictive temperature of 25uC, and stable
extrachromosomal strains established. Transgenic animals were
selected, their progeny allowed to hatch after which they were
shifted to restrictive temperature; 4 days later animals were scored.
The majority (83%) of the offspring developed into dauers, 16%
were arrested larvae and less then 1% developed into the adult
hermaphrodites, indicating that Ac-DAF-16 can partially rescue
the dauer phenotype (Fig. 4 A and B). Single mutation on S381
and double mutations on two of the AKT phosphorylation sites
S107, T312 and S381 had no effect on the capability of Ac-DAF-
16 to rescue the dauer phenotype. Only worms expressing the Ac-
DAF-16 single mutants S107A and T312A or the triple mutant
showed statistically significant development to the adult (p-
values,0.0002; Fig. 4 A and B).
Dauer exit of transgenic C. elegans daf-2;daf-16 dauers
We hypothesized that Ac-DAF-16 is one of the major regulators
of exit from the developmentally arrest L3 stage during hookworm
infection of the host. Therefore, we asked whether transgenic C.
elegans dauers are able to exit dauer. We predicted that daf-2;daf-16
dauers expressing wildtype Ac-DAF-16 would exit the dauer stage
and develop into adults when returned to permissive temperatures.
We would further expect that daf-2;daf-16 dauers expressing AKT
phosphorylation mutants of Ac-DAF-16 might fail to exit dauer,
depending on the importance of the mutated sites for 14-3-3
binding. For example, triple mutated Ac-DAF-16 would not be
phosphorylated by AKT and therefore dauers expressing the Ac-
DAF-16 triple mutant would not be expected to exit dauer. Single
mutations, however, might have a more subtle effect, and some
dauers may be able to progress in development.
To determine the effect of phosphorylation site mutations on
dauer exit, we isolated dauer larvae after 4 days incubation at
restrictive temperature, followed by incubation at the permissive
temperature of 16uC. All of the control daf-2(e1370) dauers
recovered at permissive temperature. Surprisingly, most of dauers
developed to L4/adults in transgenic lines expressing Ac-DAF-16
(Fig. 4C and D). However, fewer of the dauers carrying the Ce-
DAF-16 transgene formed adults; about 51% of dauer larvae died,
14% remained dauers and only 35% were able to resume
development. Most of the dauer larvae expressing wildtype Ac-
DAF-16 exited dauer and developed into adults (72%), whereas
23% died and only 5% persisted as dauer larvae. A similar
outcome was seen for the Ac-DAF-16 single mutant S381A (74%
adults, 6% dauer larvae) and the Ac-DAF-16 double mutant
T312A/ S381A (73% adults, 8% dauer larvae). A significantly
higher fraction remained as dauer larvae when Ac-DAF-16 was
mutated on the first and/or second, first and third phosphoryla-
tion site, and on all three phosphorylation site. We found 15% of
the larvae were dauers in the S107A mutants, 9% in the T312A
mutants, and 11% each in the S107A/T312A and S107A/S381A
mutant. When all three sites were mutated, 17% of the larvae
remained dauers, 23% died and 60% developed to the L4/adult
stage. The statistical analysis indicated that phosphorylation on
S107 and T312 are the most important residues for AKT
regulation of Ac-DAF-16. Both residues were previously shown to
be required for 14-3-3 binding [27]. However, most dauer larvae
recovered even when all three AKT regulation sites were mutated.
This suggests that an AKT-independent mechanism is involved in
the regulation of Ac-DAF-16 in C. elegans during the dauer exit. It
further suggests that hookworm L3 might exit arrest similarly by
an AKT-independent mechanism.
Localization of Ac-DAF-16 expressed in C. elegans during
dauer and dauer exit
Regulation of DAF-16 by IIS is associated with shuttling from
the nucleus to the cytoplasm. However, the majority of transgenic
larvae entered and exited the dauer stage, even without
phosphorylation-competent sites. Therefore, we asked where Ac-
DAF-16 is localized during dauer and when the larvae exit the
dauer stage, and whether mutations on the AKT phosphoryla-
tion sites affect its localization. Using confocal microscopy, the
localization of wildtype and phosphorylation site mutant Ac-DAF-
16::GFP fusion proteins was determined in dauers and recovering
dauers 16 h after downshift to 16uC. At this time, the larvae were
recovering, but remained morphologically dauers.
In dauer larvae incubated at 25uC, Ac-DAF-16 wildtype was
localized primarily in nuclei of hypodermal and body wall muscle
cells, as well as some intestinal cells; these cells also had very low
cytoplasmic levels of GFP. Wildtype Ac-DAF-16 was never
observed exclusively in the nuclei of any cells in dauers (Fig. 5).
When dauer larvae were downshifted to 16uC, wildtype Ac-DAF-
16 was expressed in the same cells, predominantly in the nuclei,
Relative luciferase activity of cells cultivated without serum, treated
with insulin and subsequent treated with IIS inhibitors. LY294009 is a
specific inhibitor of PIP3K and AKT Inhibitor IV and IX specifically inhibit
AKT. The luciferase activity is depicted relative to starved cells (100%
gene expression) and to insulin treated cells (0% expression). C)
Comparison of DBE-driven transcription of Ac-DAF-16 wildtype and
AKT-phospho-mutants when cells were treated as described in A).
doi:10.1371/journal.pone.0025996.g003
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but a higher proportion was localized in the cytoplasm. Single or
multiple mutations on S107, S381 and T312 in Ac-DAF-16 did not
alter the localization pattern in the different cell types (Fig. 5 and
6), but the mutations did affect sub-cellular localization. These
differences were quantified by counting dauers with purely nuclear
DAF-16::GFP signal and those with DAF-16::GFP in both cellular
compartments. Exclusively cytoplasmic expression of either wild-
type or mutated Ac-DAF-16 was never observed. As shown in
Figure 7, Ac-DAF-16 S107A was more frequently localized in the
nuclei of dauer larvae, and larvae with exclusively nuclear
localization were observed. Induction of dauer exit shifted the
localization towards the cytoplasmic compartment so that Ac-
DAF-16 (S107A) was found in both compartments in all worms. A
similar response was observed in dauers expressing Ac-DAF-16
single mutant T312A and the double mutants (S107A/T312A,
S107A/S381A and T312A/ S381A) during dauer and dauer exit.
Dauers expressing the single Ac-DAF-16 mutation S318A and the
triple mutant showed a different pattern. In these cases, DAF-16
remained in the nucleus in a significant number of dauers during
dauer exit, although slightly less so in the triple mutant Ac-DAF-
16. These data indicate that the S381 site can mediate nuclear
exclusion during dauer recovery.
Discussion
Recent publications from our lab and others support the
hypothesis that recovery from developmental arrest by the
hookworm and other parasitic nematode infective stages is
regulated by IIS [27,29,34,35], similar to recovery from dauer in
C. elegans [36]. Here we provide further evidence supporting a
role for IIS in hookworm L3 recovery, in addition to evidence
indicating that another, as yet undefined, mechanism is also
Figure 4. Ac-DAF-16 complements missing endogenous Ce –DAF-16 in C. elegans double mutant daf-2; daf-16. A) Rescue of dauer
defective phenotype of C. elegans daf-2;daf-16 mutants by Ac-DAF-16 wildtype and AKT phosphorylation mutants at 25uC. B) Chi-square analysis of A)
showing significant p-values in bolt. C) Recovery of SDS isolated dauers complemented with Ac-DAF-16 wildtype and AKT phospho-mutants at 16uC.
D) Chi-square analysis of C.
doi:10.1371/journal.pone.0025996.g004
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involved. Using cell-based approaches and in vitro assays, we
demonstrated that hookworm DAF-16 is a downstream target of
IIS and a substrate of AKT kinase. Sub-cellular fractionation of
transfected cell lines indicated that a fraction of nuclear localized
Ac-DAF-16 in starved cells is shuttled to the cytoplasm in response
to serum, and Ac-DAF-16-driven transcription from the conserved
DBE was sensitive to insulin in cell culture. Together, these data
suggest that IIS mediates negative regulation of Ac-DAF-16.
Furthermore, complementation of C. elegans dauer defective
mutants with Ac-DAF-16 restored the dauer phenotype, confirm-
ing that Ac-DAF-16 is orthologous to Ce-DAF-16, and can function
in C. elegans dauer formation in the absence of functional
endogenous DAF-16.
While dauer formation has been a useful paradigm for framing
questions about hookworm developmental signaling, dauer recov-
ery is a more relevant process to the resumption of development that
occurs when hookworm L3 infect a permissive host. However, there
have been few investigations of dauer recovery reported in C. elegans.
For the first time, we examined the role of a heterologous DAF-16 in
recovery from dauer arrest using wildtype and phospho-null AKT
site mutants of hookworm DAF-16 in transgenic dauer larvae.
Transgenic C. elegans dauers expressing wildtype Ac-DAF-16 re-
covered from dauer when shifted to permissive temperature, as
would be expected for a DAF-16 ortholog. Surprising, however,
dauers expressing the phospho-null mutant Ac-DAF-16 also
recovered, indicating that the intact, phosphorylation-capable
AKT sites were not required for dauer recovery. This also suggests
that a mechanism other than AKT/14-3-3 mechanism can mediate
dauer recovery in C. elegans, and by extension, hookworms.
We also examined the localization of GFP labeled Ac-DAF-16
during dauer and dauer recovery. In general, the tissue expression
pattern of transgenic Ac-DAF-16 in the C. elegans daf-2;daf-16
mutants conformed to expression of Ce-DAF-16 under the pdaf16a
promoter, namely expression in hypodermis, intestine, body wall
muscles and neurons [8,34]. Dauers expressing wildtype Ac-DAF-
16 had some cells that had exclusively nuclear localized DAF-16,
but no worms were found that had nuclear expression in all cells.
This was similar to our cell culture results, in which Ac-DAF-16
was found distributed between both the nuclear and cytoplasmic
compartments in starved cells, the equivalent of dauers in that they
lack significant levels of IIS. This mixed distribution suggests that
some shuttling is occurring even under low insulin signaling
conditions. Interestingly, 40–60% of transgenic dauers expressing
Ac-DAF-16::GFP with any phospho-null AKT site mutation
showed exclusively nuclear localization of DAF-16, suggesting
that basal levels of 14-3-3 shuttling require phosphorylation of
these sites in the dauer.
During recovery, localization of wildtype Ac-DAF-16 shifted
from the nucleus to the cytoplasm, in accordance with AKT
phosphorylation and the 14-3-3 shuttle mechanism mediated by
IIS. Similarly, all of the transgenic worms expressing exclusively
nuclear localized phospho-null Ac-DAF-16 underwent a shift to
mixed cytoplasmic and nuclear expression with the exception of
the S381A mutant, in which only 8% of the worms switched to
Figure 5. Cellular localization of Ac-DAF-16 wildtype and single AKT-phospho-mutants in dauer larvae. Pictures are lambda stack
images from transgenic daf-2;daf-16 dauers, expressing fusion constructs of A) Ac-DAF-16 wildtype, single mutants B) Ac-DAF-16 (S107A), C) Ac-DAF-
16 (T312A), D) Ac-DAF-16 (S381A). ‘‘a’’ indicates the anterior end.
doi:10.1371/journal.pone.0025996.g005
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mixed localization. Approximately 11% of the triple mutants also
retained DAF-16 in their nuclei. This indicates a role for S381 in
translocation of DAF-16 to the cytoplasm during dauer recovery.
The requirement for an intact S381 is not absolute, however, as all
double mutants containing S381A showed nuclear localization
during recovery. This suggests that at least two independent
mechanisms control DAF-16 translocation during recovery. One
mechanism requires either intact S107 or T312 sites on DAF-16
for shuttling, whereas the other requires an intact S381 site. AKT
phosphorylation sites S107 and T312, but not S381, were shown
to be required for interaction with hookworm 14-3-3 [27],
suggesting that the S107/T312-dependent mechanism may
represent the canonical AKT/14-3-3 shuttle [14], and that S381
mediates a 14-3-3-independent translocation of DAF-16 from
the nucleus to the cytoplasm during dauer recovery. Previous
publications suggested already that shuttling is not a requirement
to silence DAF-16/FoxO transcriptional activity as shown in cell
based assays [14,37], but a mechanism was not defined.
As all of the worms expressing phospho-null Ac-DAF-16
recovered from dauer, even those lacking site S381 and the triple
mutants, recovery from arrest does not require phosphorylation of
the known AKT sites in Ac-DAF-16. Furthermore, while Ac-DAF-
16 exits the nucleus during recovery, translocation is not essential,
as most worms expressing S381 phospho-null Ac-DAF-16 recover
from dauer despite retention of DAF-16 in the nucleus. This
suggests that a molecular mechanism independent of, or in addition
to, AKT can negatively regulate DAF-16 activity in response to IIS.
Additional outputs of AKT or other IIS kinases might indirectly
regulate DAF-16.
Numerous studies describing the role of DAF-16 and IIS in C.
elegans dauer formation and aging have been reported. DAF-16
expression in neurons is required to restore the dauer phenotype in
dauer defective daf-2;daf-16 mutants, whereas intestinal expression
is required for increased longevity [28]. Expression of wildtype and
mutated versions of Ac-DAF-16 were sufficient to restore the dauer
phenotype in dauer defective daf-2;daf-16 mutants, suggesting
neuronal expression in transgenic dauers during recovery despite
our inability to confirm this visually. However, we could not
identify a comparable study addressing the localization of DAF-16
during dauer exit. In transgenic Strongyloides stercoralis L1,
Castelletto et al showed that phospho-null mutants of the DAF-
16 ortholog Ss-FKTF-1 are trapped inside the nucleus because
AKT/14-3-3 binding sites are missing [35], but the localization of
Ss-FKTF-1 during dauer exit was not addressed. Therefore, we
showed for the first time that DAF-16 of parasitic origin shuttles
from the nucleus to cytoplasm during dauer exit in a process that is
not exclusively dependent on AKT/14-3-3 regulation. Comple-
mentation assays of C. elegans double mutants with Ss-Fktf-1 also
restored the dauer phenotype [34], but the cellular localization of
Ss-FKTF-1 was not reported. In the same study, complementation
with the homogenous Ce-DAF-16 restored the dauer phenotype in
a lower percentage of worms than complementation with the
heterologous parasite transcription factor [34]. We saw similar
results in the dauer exit assays, a higher proportion of dauers
Figure 6. Cellular localization of Ac-DAF-16 double and triple AKT-phospho-mutants in dauer larvae. Pictures are lambda stack images
from transgenic daf-2;daf-16 dauers, expressing fusion constructs of double mutants E) Ac-DAF-16 (S107A/T312A), F) Ac-DAF-16 (S107A/S381A), G)
Ac-DAF-16 (T312A/ S381A) and H) Ac-DAF-16 triple mutant. ‘‘a’’ indicates the anterior end.
doi:10.1371/journal.pone.0025996.g006
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expressing Ac-DAF-16 exited than Ce-DAF-16 expressing dauers.
The reason for this anomaly is unknown, but may be construct-
related.
Cahill et al reported 14-3-3 dependent and independent
regulation of DAF-16 ectopically expressed in HepG2 cells
[14]. Our cell based approach, using Ac-DAF-16 wildtype and
AKT site mutants, confirms the results and showed that even
AKT/14-3-3 null mutants were insulin sensitive. Furthermore, all
cells expressing Ac-DAF-16 variants reacted much more strongly
to insulin than to FBS, suggesting regulation of Ac-DAF-16 is
highly complex, and that regulation in response to other growth
factors in addition to insulin contained in FBS might be involved
as well. Also, cell based assays involving growth factor treatment
to assess DAF-16 regulation must be interpreted carefully, as
ubiquitinylation processes have been reported to lead to
degradation of FoxO proteins [33,38]. However, in addition to
the cell based assay, our dauer rescue and recovery data strongly
suggest that an additional, AKT/14-3-3-independent mechanism
regulates Ac-DAF-16.
As DAF-16 is a convergence point for several developmental
pathways, it is also regulated by IIS dependent and independent
outputs from these pathways [39–46]. These include co-transla-
tional (i.e. myristylation) and post-translational modifications like
acetylation, deacetylation, methylation, dephosphorylation, and
phosphorylation by kinases other than AKT. The role of these
regulatory mechanisms in recovery from dauer and L3 arrest are
unknown, but it is possible that these may play a more significant
role in regulating hookworm L3 DAF-16 than in the C. elegans
dauer stage. Further investigations are necessary to shed light on
the regulation of the hookworm L3 arrest and the role of IIS, as
well as IIS independent mechanisms in the re-activation of
infective, developmentally arrested hookworms.
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